Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021

Detalles Bibliográficos
Autores principales: Lutrick, Karen, Rivers, Patrick, Yoo, Young M., Grant, Lauren, Hollister, James, Jovel, Krystal, Khan, Sana, Lowe, Ashley, Baccam, Zoe, Hanson, Hanna, Olsho, Lauren E.W., Fowlkes, Ashley, Caban-Martinez, Alberto J., Porter, Cynthia, Yoon, Sarang, Meece, Jennifer, Gaglani, Manjusha, Burns, Joy, Mayo Lamberte, Julie, Nakayima Miiro, Flavia, Bissonnette, Adam, LeClair, Lindsay, Kutty, Preeta K., Romine, James K., Stefanski, Elisha, Edwards, Laura J., Ellingson, Katherine, Gerald, Joe K., Bedrick, Edward J., Madhivanan, Purnima, Krupp, Karl, Gerald, Lynn B., Thompson, Mark, Burgess, Jefferey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736269/
https://www.ncbi.nlm.nih.gov/pubmed/34968373
http://dx.doi.org/10.15585/mmwr.mm705152a2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736269/
https://www.ncbi.nlm.nih.gov/pubmed/34968373
http://dx.doi.org/10.15585/mmwr.mm705152a2

Ejemplares similares